Applied Dna Sciences Accounts Payable

Applied Dna Sciences (APDN) currently reports a accounts payable of $0 as of June 2026. That compares with $610K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Applied Dna Sciences's accounts payable history and peer comparisons.

Applied Dna Sciences's accounts payable decreased from $610K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Dna Sciences reported $0 in accounts payable as of June 2026. That compares with $610K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Dna Sciences, and consider following APDN for alerts when major investors trade the stock.

Applied Dna Sciences is classified in the Materials sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing APDN with unrelated industries.